SC
TMO icon

Solstein Capital’s Thermo Fisher Scientific TMO Stock Holding History

Solstein Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$965K Sell
1,964
-1,700
-46% -$923K 0.4% 60
2025
Q4 		$2.12M Hold
3,664
– – 0.85% 30
2025
Q3 		$1.78M Sell
3,664
-65
-2% -$30.3K 0.4% 32
2025
Q2 		$1.51M Sell
3,729
-852
-19% -$356K 0.78% 30
2025
Q1 		$2.28M Hold
4,581
– – 1.33% 18
2024
Q4 		$2.38M Hold
4,581
– – 1.33% 16
2024
Q3 		$2.83M Sell
4,581
-74
-2% -$43.8K 1.5% 17
2024
Q2 		$2.57M Hold
4,655
– – 1.68% 14
2024
Q1 		$2.71M Sell
4,655
-153
-3% -$85.9K 1.88% 13
2023
Q4 		$2.55M Sell
4,808
-125
-3% -$60.5K 1.89% 12
2023
Q3 		$2.5M Sell
4,933
-18
-0.4% -$9.59K 2.15% 11
2023
Q2 		$2.58M Buy
4,951
+46
+0.9% +$24.8K 2.15% 11
2023
Q1 		$2.83M Sell
4,905
-341
-7% -$192K 2.46% 9
2022
Q4 		$2.89M Sell
5,246
-384
-7% -$203K 2.42% 9
2022
Q3 		$2.85M Buy
5,630
+92
+2% +$51.5K 2.52% 8
2022
Q2 		$3.01M Sell
5,538
-55
-1% -$30.3K 2.3% 7
2022
Q1 		$3.3M Sell
5,593
-327
-6% -$188K 2.18% 11
2021
Q4 		$3.95M Buy
5,920
+1
+0% +$624 2.38% 6
2021
Q3 		$3.38M Buy
5,919
+3,710
+168% +$2.04M 1.94% 7
2021
Q2 		$1.11M Buy
2,209
+177
+9% +$83.5K 1.37% 17
2021
Q1 		$927K Buy
2,032
+82
+4% +$39.1K 1.26% 22
2020
Q4 		$911 Sell
1,950
-942
-33% -$442K 0.38% 13
2020
Q3 		$1.28M Sell
2,892
-222
-7% -$91.7K 2.86% 7
2020
Q2 		$1.13M Sell
3,114
-447
-13% -$150K 2.68% 6
2020
Q1 		$1.01M Sell
3,561
-1,771
-33% -$558K 3.89% 8
2019
Q4 		$1.73M Buy
5,332
+3,060
+135% +$928K 3.49% 6
2019
Q3 		$641K Buy
2,272
+72
+3% +$20.6K 5.69% 7
2019
Q2 		$646K Buy
2,200
+1,000
+83% +$275K 4.14% 8
2019
Q1 		$328K Hold
1,200
– – 1.85% 18
2018
Q4 		$269K Buy
+1,200
New +$282K 1.57% 19

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Solstein Capital's TMO Position: Q1 2026 in Review

Solstein Capital reduced its Thermo Fisher Scientific (TMO) stake by 46% in Q1 2026, selling an estimated $923K and leaving 1,964 shares worth $965K. The position accounts for 0.4% of the portfolio, ranked #60.

Solstein Capital first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.95M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Solstein Capital held 1,964 shares of Thermo Fisher Scientific worth $965K as of Q1 2026.
  • Solstein Capital sold 1,700 Thermo Fisher Scientific shares in Q1 2026, an estimated $923K.
  • Thermo Fisher Scientific made up 0.4% of Solstein Capital's portfolio in Q1 2026, its #60 holding.
  • Solstein Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Solstein Capital's Thermo Fisher Scientific position peaked at $3.95M in Q4 2021.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.